Lisa C Richardson1, Antonio J Neri, Eric Tai, Jeffrey D Glenn. 1. Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA. lrichardson@cdc.gov
Abstract
BACKGROUND: Testicular cancer (TC) is one of the most curable cancers. Given survival rates of close to 100% with appropriate therapy, ensuring proper treatment is essential. We reviewed and summarized the literature on the association of socioeconomic position (SEP) along the cancer control spectrum from risk factors to survivorship. METHODS: We searched PubMed from 1966 to 2011 using the following terms: testicular cancer, testicular neoplasm, poverty, and socioeconomic factors, retrieving 119 papers. After excluding papers for the non-English (10) language and non-relevance (46), we reviewed 63 papers. We abstracted information on socioeconomic position (SEP), including occupation, education, income, and combinations of the 3. Five areas were examined: risk factors, diagnosis, treatment, survival, and survivorship. RESULTS: Most studies examined area-based measures, not individual measures of SEP. The majority of studies found an increased risk of developing TC with high SEP though recent papers have indicated increased risk in low-income populations. Regarding diagnosis, recent papers have indicated that lower levels of education and SEP are risk factors for later-stage TC diagnosis and hence higher TC mortality. For treatment, 1 study that examined the use of radiation therapy (RT) in stage I seminoma reported that living in a county with lower educational attainment led to lower use of RT. For survival (mortality), several studies found that men living in lower SEP geographic areas experience lower survival and higher mortality. CONCLUSION: The strongest evidence for SEP impact on testicular germ cell tumor (TGCT) was found for the risk of developing cancer as well as survival. The association of SEP with TGCT risk appears to have changed over the last decade. Given the highly curable nature of TGCT, more research is needed to understand how SEP impacts diagnosis and treatment for TGCT and to design interventions to address disparities in TGCT outcomes and SEP. Published by Elsevier Inc.
BACKGROUND:Testicular cancer (TC) is one of the most curable cancers. Given survival rates of close to 100% with appropriate therapy, ensuring proper treatment is essential. We reviewed and summarized the literature on the association of socioeconomic position (SEP) along the cancer control spectrum from risk factors to survivorship. METHODS: We searched PubMed from 1966 to 2011 using the following terms: testicular cancer, testicular neoplasm, poverty, and socioeconomic factors, retrieving 119 papers. After excluding papers for the non-English (10) language and non-relevance (46), we reviewed 63 papers. We abstracted information on socioeconomic position (SEP), including occupation, education, income, and combinations of the 3. Five areas were examined: risk factors, diagnosis, treatment, survival, and survivorship. RESULTS: Most studies examined area-based measures, not individual measures of SEP. The majority of studies found an increased risk of developing TC with high SEP though recent papers have indicated increased risk in low-income populations. Regarding diagnosis, recent papers have indicated that lower levels of education and SEP are risk factors for later-stage TC diagnosis and hence higher TC mortality. For treatment, 1 study that examined the use of radiation therapy (RT) in stage I seminoma reported that living in a county with lower educational attainment led to lower use of RT. For survival (mortality), several studies found that men living in lower SEP geographic areas experience lower survival and higher mortality. CONCLUSION: The strongest evidence for SEP impact on testicular germ cell tumor (TGCT) was found for the risk of developing cancer as well as survival. The association of SEP with TGCT risk appears to have changed over the last decade. Given the highly curable nature of TGCT, more research is needed to understand how SEP impacts diagnosis and treatment for TGCT and to design interventions to address disparities in TGCT outcomes and SEP. Published by Elsevier Inc.
Authors: Lorenzo Richiardi; Olof Akre; Mats Lambe; Fredrik Granath; Scott M Montgomery; Anders Ekbom Journal: Epidemiology Date: 2004-05 Impact factor: 4.822
Authors: Maxine Sun; Firas Abdollah; Daniel Liberman; Al'a Abdo; Rodolphe Thuret; Zhe Tian; Shahrokh F Shariat; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz Journal: Cancer Date: 2011-03-08 Impact factor: 6.860
Authors: Marie Walschaerts; Audrey Muller; Jacques Auger; Louis Bujan; Jean-François Guérin; Dominique Le Lannou; André Clavert; Alfred Spira; Pierre Jouannet; Patrick Thonneau Journal: Int J Androl Date: 2007-08
Authors: Bruna Galobardes; Mary Shaw; Debbie A Lawlor; John W Lynch; George Davey Smith Journal: J Epidemiol Community Health Date: 2006-01 Impact factor: 3.710
Authors: Wen-Jung Chen; Cheng-Yu Huang; Yu-Hui Huang; Shao-Chuan Wang; Tzuo-Yi Hsieh; Sung-Lang Chen; Wen-Wei Sung; Tsung-Hsien Lee Journal: Int J Environ Res Public Health Date: 2019-12-23 Impact factor: 3.390
Authors: Aldo Spanjaard; Ronak Shah; Daniël de Groot; Olimpia Alessandra Buoninfante; Ben Morris; Cor Lieftink; Colin Pritchard; Lisa M Zürcher; Shirley Ormel; Joyce J I Catsman; Renske de Korte-Grimmerink; Bjørn Siteur; Natalie Proost; Terry Boadum; Marieke van de Ven; Ji-Ying Song; Maaike Kreft; Paul C M van den Berk; Roderick L Beijersbergen; Heinz Jacobs Journal: Nucleic Acids Res Date: 2022-07-22 Impact factor: 19.160
Authors: Margaret Ottaviano; Emilio Francesco Giunta; Pasquale Rescigno; Ricardo Pereira Mestre; Laura Marandino; Marianna Tortora; Vittorio Riccio; Sara Parola; Milena Casula; Panagiotis Paliogiannis; Antonio Cossu; Ursula Maria Vogl; Davide Bosso; Mario Rosanova; Brunello Mazzola; Bruno Daniele; Giuseppe Palmieri; Giovannella Palmieri Journal: Int J Mol Sci Date: 2021-07-02 Impact factor: 5.923
Authors: Andrea Garolla; Damiano Pizzol; Alessandro Bertoldo; Marco Ghezzi; Umberto Carraro; Alberto Ferlin; Carlo Foresta Journal: Front Endocrinol (Lausanne) Date: 2012-12-21 Impact factor: 5.555